NCT06882577Recruiting
Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy
Source: ClinicalTrials.gov · Last updated 13 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy (HEART) is a single-center observational registry evaluating the heart of patients hospitalized for acute ischemic stroke with reperfusion therapy. This registry aims to establish quantified risk stratification and prognostic models, as well as suggest effective diagnostic and therapeutic strategies.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 10 Mar 2025
- Start date
- 31 Mar 2025
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- Soochow University
- Diseases
- Stroke
- NCT number
- NCT06882577
What you commit to
- Study type: Observational
- Planned participants: 400
- From 31 Mar 2025 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Pregnancy and / or breast-feeding.
- Participation in an interventional study.
- Patients refuse to participate in the research.
Who the study is looking for
- Written informed consent by patient
- Age ≥ 18 years
- Acute ischemic stroke (with matching brain lesion on MR imaging)
- Enrolment within 24 h after onset of stroke-related symptoms.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Soochow University Coordinator of this site? Confirm its status | Suzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.